The authorisation represents the DEXTER system’s second FDA clearance relating to gynaecology.
Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications ...
The Swiss robotic surgery company, which is rolling out its Dexter system in the U.S., said the new indications will help ...
Distalmotion announced today that it received FDA 510(k) clearance for its Dexter surgical robot in a range of gynecology ...
Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.
Lausanne, Switzerland, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Distalmotion - a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating ...
Lausanne, Switzerland, June 24, 2025 (GLOBE NEWSWIRE) -- Distalmotion, a global MedTech company advancing access to robotic surgery, has reached a key milestone in its US expansion with the first ...
Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has ...